Submit Your Paper Instructions for Authors Instructions for Reviewers Editor in Chief Editorial Board Editorial Policies English Editing Service Indexing and Abstracting Archive

Collaborator of

2025, Vol 17, No. 1

Journal of Cardiovascular and Thoracic Research (JCVTR) is an international, open access and peer-reviewed journal affiliated with the Iranian Heart Association. It covers all aspects of cardiovascular researches and accepts various types of scientific papers from letter and commentary, to review and original research.

Original Article

1. Outcome of Diabetic and Non-Diabetic Patients Undergoing Successful Percutaneous Coronary Intervention of Chronic Total Occlusion

Bahram Sohrabi, Samad Ghaffari, Afshin Habibzadeh*, Parastoo Chaichi

J Cardiovasc Thorac Res. 2011;3(2): 45-48. doi: 10.5681/jcvtr.2011.009

PMCID: PMC3825329 PMID: 24250951

Article

PDF

XML

Cited By:

Original Article

2. Activated clotting time level with weight based heparin dosing during percutaneous coronary intervention and its determinant factors

Majid Soleimannejad, Naser Aslanabadi, Bahram Sohrabi, Morteza Shamshirgaran, Ahmad Separham, Babak Kazemi, Ebrahim Khayati Shal, Reza Madadi, Hamidreza Shirzadi, Hoda Azizi, Samad Ghaffari*

J Cardiovasc Thorac Res. 2014;6(2): 97-100. doi: 10.5681/jcvtr.2014.021

PMCID: PMC4097859 PMID: 25031824

Article

PDF

XML

Cited By:

Original Article

3. Increased risk of coronary perforation during percutaneous intervention of myocardial bridge: What histopathology says

Somayeh Pourhoseini, Mohammad Bakhtiari, Abdolreza Babaee, Mohammad Ali Ostovan, Seyed Hassan Eftekhar-Vaghefi, Nikan Ostovan, Pooyan Dehghani*

J Cardiovasc Thorac Res. 2017;9(2): 108-112. doi: 10.15171/jcvtr.2017.18

PMCID: PMC5516050 PMID: 28740631

Article

PDF

XML

Cited By:

Case Report

4. Delayed diagnosis of myocardial infarction in a young man with a blunt chest trauma

Marzieh Nikparvar , Sayed Mohammadbagher Asghari, Hossein Farshidi*

J Cardiovasc Thorac Res. 2019;11(3): 251-253. doi: 10.15171/jcvtr.2019.42

PMCID: PMC6759617 PMID: 31579468

Article

PDF

XML

Cited By:

Original Article

5. Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention

Ata Firouzi, Ali Kazem Moussavi, Ahmad Mohebbi, Mohammad Javad Alemzadeh-Ansari*, Reza Kiani, Hamid Reza Sanati, Bahram Mohebbi, Farshad Shakerian, Ali Zahedmehr, Mohammad Mostafa Ansari-Ramandi, Saeed Oni Heris, Bahar Ghaleshi, Fatemeh Ghorbani

J Cardiovasc Thorac Res. 2018;10(3): 149-152. doi: 10.15171/jcvtr.2018.24

PMCID: PMC6203872 PMID: 30386535

Article

PDF

XML

Cited By:

Case Report

6. Unexpected complications of vasospastic coronary artery disease and its successful management

Gülay Gök, Tufan Çinar*

J Cardiovasc Thorac Res. 2019;11(2): 164-166. doi: 10.15171/jcvtr.2019.28

PMCID: PMC6669425 PMID: 31384413

Article

PDF

XML

Cited By:

Original Article

7. Association between the risks of contrast-induced nephropathy after diagnostic or interventional coronary management and the transradial and transfemoral access approaches

Ata Firouzi , Mohammad Javad Alemzadeh-Ansari* , Naser Mohammadhadi* , Mohammad Mehdi Peighambari, Ali Zahedmehr, Bahram Mohebbi, Reza Kiani, Hamid Reza Sanati, Farshad Shakerian, Alireza Rashidinejad, Behshid Ghadrdoost, Raana Asghari, Simin Shokrollahi Yancheshmeh

J Cardiovasc Thorac Res. 2020;12(1): 51-55. doi: 10.34172/jcvtr.2020.08

PMCID: PMC7080339 PMID: 32211138 Scopus ID: 85096934126

Article

PDF

XML

Cited By:

Original Article

8. A simple score for the prediction of stent thrombosis in patients with ST elevation myocardial infarction: TIMI risk index

Tufan Çınar* , Yavuz Karabağ , Cengiz Burak , Veysel Ozan Tanık , Mahmut Yesin , Metin Çağdaş , İbrahim Rencüzoğulları

J Cardiovasc Thorac Res. 2019;11(3): 182-188. doi: 10.15171/jcvtr.2019.31

PMCID: PMC6759620 PMID: 31579457

Article

PDF

XML

Cited By:

Case Report

9. Diffuse alveolar hemorrhage; An under-diagnosed and rare complication of glycoprotein IIb/IIIa inhibitors

Hamidreza Hekmat , Zahra Vahabi , Maryam Shojaeifard , Fatemeh Sadat Mirzadeh*

J Cardiovasc Thorac Res. 2022;14(3): 201-204. doi: 10.34172/jcvtr.2022.17

PMCID: PMC9617063 PMID: 36398050 Scopus ID: 85140394334

Article

PDF

Full Text

XML

Cited By:

Original Article

10. CHA₂ DS₂ -VASc score, a simple clinical tool for early prediction of no-reflow phenomenon in patients undergoing emergency percutaneous coronary revascularization

Abdul Hakeem Shaikh , Rajesh Kumar* , Ali Ammar, Afzal Hussain, Muhammad Naeem Mengal, Kamran Ahmed Khan, Danish Qayyum, Jawaid Akbar Sial, Tahir Saghir, Musa Karim

J Cardiovasc Thorac Res. 2022;14(2): 122-127. doi: 10.34172/jcvtr.2022.19

PMCID: PMC9339737 PMID: 35935384 Scopus ID: 85140840205

Article

PDF

Full Text

XML

Cited By:

Original Article

11. Optical coherence tomography characterization of spontaneous recanalized coronary thrombus – Single center experience

Ankit Gupta , Raghavendra Rao K, Sreenivas Reddy S* , Jeet Ram Kashyap, Vikas Kadiyala, Jaspreet Kaur, Debabrata Dash, Suraj Kumar, Munish Dev

J Cardiovasc Thorac Res. 2022;14(4): 220-227. doi: 10.34172/jcvtr.2022.30504

PMCID: PMC9871162 PMID: 36699554

Article

PDF

Full Text

XML

Cited By:

Original Article

12. The relationship between H2FPEF score and contrast induced nephropathy in patients with ST elevation myocardial infarction

Ufuk Sadik Ceylan , Ersin Yıldırım*

J Cardiovasc Thorac Res. 2022;14(4): 240-245. doi: 10.34172/jcvtr.2022.30537

PMCID: PMC9871164 PMID: 36699560

Article

PDF

Full Text

XML

Cited By:

Case Series

13. Clinical outcomes of transcatheter closure of congenital coronary artery fistula in 28 cases

Azin Alizadehasl , Ata Firouzi, Zahra Khajali, Ehsan Khalilipur, Zahra Hosseini, Hanieh Nezhadbahram, Tayebe Mohamad Gholizad, Fateme Amini, Tahere Sahraee, Shoeib Dehbandi, Seyed Ehsan Parhizgar*

J Cardiovasc Thorac Res. 2024;16(2): 135-141. doi: 10.34172/jcvtr.31823

PMCID: PMC11380750 PMID: 39253348

Article

PDF

Full Text

XML

Cited By:

Original Article

14. Evaluating the effects of empagliflozin in preventing myocardial injury in patients undergoing percutaneous coronary intervention: A double-blind, randomized clinical trial

Hossein Behzad , Sina Mashayekhi, Hila Asham, Parvin Sarbakhsh, Taher Entezari-Maleki*

J Cardiovasc Thorac Res. 2024;16(2): 113-119. doi: 10.34172/jcvtr.33103

PMCID: PMC11380744 PMID: 39253345

Article

PDF

Full Text

XML

Cited By:

Original Article

15. Impact of prior aspirin use on left ventricular function in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: An echocardiographic evaluation

Yosef Yosefzadeh , Mahdokht Rezaei* , Abbas Allami* , Ali Hosseinsabet

J Cardiovasc Thorac Res. 2024;16(3): 164-170. doi: 10.34172/jcvtr.33184

PMCID: PMC11489634 PMID: 39430282

Article

PDF

Full Text

XML

Cited By:

Platinum Open Access

This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website and open access repositories such as PubMed Central. All related costs for processing of the manuscripts are sponsored by Tabriz University of Medical Sciences.

Indexing Info

1. Outcome of Diabetic and Non-Diabetic Patients Undergoing Successful Percutaneous Coronary Intervention of Chronic Total Occlusion

2. Activated clotting time level with weight based heparin dosing during percutaneous coronary intervention and its determinant factors

3. Increased risk of coronary perforation during percutaneous intervention of myocardial bridge: What histopathology says

4. Delayed diagnosis of myocardial infarction in a young man with a blunt chest trauma

5. Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention

6. Unexpected complications of vasospastic coronary artery disease and its successful management

7. Association between the risks of contrast-induced nephropathy after diagnostic or interventional coronary management and the transradial and transfemoral access approaches

8. A simple score for the prediction of stent thrombosis in patients with ST elevation myocardial infarction: TIMI risk index

9. Diffuse alveolar hemorrhage; An under-diagnosed and rare complication of glycoprotein IIb/IIIa inhibitors

10. CHA2 DS2 -VASc score, a simple clinical tool for early prediction of no-reflow phenomenon in patients undergoing emergency percutaneous coronary revascularization

11. Optical coherence tomography characterization of spontaneous recanalized coronary thrombus – Single center experience

12. The relationship between H2FPEF score and contrast induced nephropathy in patients with ST elevation myocardial infarction

13. Clinical outcomes of transcatheter closure of congenital coronary artery fistula in 28 cases

14. Evaluating the effects of empagliflozin in preventing myocardial injury in patients undergoing percutaneous coronary intervention: A double-blind, randomized clinical trial

15. Impact of prior aspirin use on left ventricular function in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: An echocardiographic evaluation

10. CHA₂ DS₂ -VASc score, a simple clinical tool for early prediction of no-reflow phenomenon in patients undergoing emergency percutaneous coronary revascularization